{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "TCR2 THERAPEUTICS  DL-,01", "longName": "TCR2 Therapeutics Inc.", "messageBoardId": "finmb_316867676", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.3150373, "regularMarketPrice": 1.726, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1550646000000, "priceHint": 4, "epsTrailingTwelveMonths": -3.45, "epsForward": -3.02, "epsCurrentYear": -2.6, "priceEpsCurrentYear": -0.66384614, "sharesOutstanding": 39244200, "bookValue": 3.593, "fiftyDayAverage": 1.42462, "fiftyDayAverageChange": 0.30137992, "fiftyDayAverageChangePercent": 0.21155109, "twoHundredDayAverage": 1.649951, "twoHundredDayAverageChange": 0.07604897, "twoHundredDayAverageChangePercent": 0.046091653, "marketCap": 69955984, "forwardPE": -0.5715232, "priceToBook": 0.4803785, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.9 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.023000002, "regularMarketTime": 1683875702, "regularMarketDayHigh": 1.726, "regularMarketDayRange": "1.726 - 1.726", "regularMarketDayLow": 1.726, "regularMarketVolume": 100, "regularMarketPreviousClose": 1.749, "bid": 1.775, "ask": 1.855, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.726, "averageDailyVolume3Month": 391, "averageDailyVolume10Day": 1280, "fiftyTwoWeekLowChange": 0.97339994, "fiftyTwoWeekLowChangePercent": 1.2933829, "fiftyTwoWeekRange": "0.7526 - 4.0", "fiftyTwoWeekHighChange": -2.2740002, "fiftyTwoWeekHighChangePercent": -0.56850004, "fiftyTwoWeekLow": 0.7526, "fiftyTwoWeekHigh": 4.0, "earningsTimestamp": 1683801000, "earningsTimestampStart": 1691411400, "earningsTimestampEnd": 1691757000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "2K7.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "100 Binney Street", "address2": "Suite 710", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "(617) 949-5200", "website": "https://www.tcr2.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TCR2 Therapeutics Inc., a clinical-stage cell therapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. Its lead product candidate is gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin-expressing solid tumors, which is in Phase 1/2 clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma and acute myeloid leukemia. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Garry E. Menzel M.B.A., Ph.D.", "age": 58, "title": "Pres, CEO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 923950, "fmt": "923.95k", "longFmt": "923,950"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 35722, "fmt": "35.72k", "longFmt": "35,722"}}, {"maxAge": 1, "name": "Dr. Alfonso Quintas Cardama M.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 685150, "fmt": "685.15k", "longFmt": "685,150"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 19133, "fmt": "19.13k", "longFmt": "19,133"}}, {"maxAge": 1, "name": "Dr. Rosemary  Harrison Ph.D.", "age": 39, "title": "Chief Bus. & Strategy Officer", "yearBorn": 1983, "fiscalYear": 2022, "totalPay": {"raw": 522544, "fmt": "522.54k", "longFmt": "522,544"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Patrick A. Baeuerle Ph.D.", "age": 64, "title": "Founder & Member of the Advisory Board", "yearBorn": 1958, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric M. Sullivan CPA", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Olagunju M.B.A.", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Carl  Mauch", "title": "Sr. Director of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Margaret  Siegel J.D.", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Angela  Justice Ph.D.", "age": 48, "title": "Chief People Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Richard  Roomberg", "title": "VP of Corp. Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 3, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}